
Pharmanutra
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
The PharmaNutra Group is a group of Italian companies based in Pisa, specialising in the pharmaceutical and nutraceutical sector. The companies PharmaNutra S.p.A., Junia Pharma S.r.l., Alesco S.r.l. and and Akern S.r.l. form part of the Group. Thanks to continuous investments in R&D, leading to the recognition of numerous patents linked to Sucrosomial® Technology and Cetylated Esters, the Group has very quickly made its name as leader in the production and sale of iron- and mineral-based nutritional supplements, and it is also considered to be one of the emerging top players in the sector of medical devices for the recovery of joint capacity.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-03 08:00 |
Regulatory News Service
Pharmanutra: Lancio ApportAL Boost
|
Italian | 189.4 KB | |
2025-06-03 08:00 |
Regulatory News Service
Pharmanutra: Launch of ApportAL Boost
|
English | 241.0 KB | |
2025-05-27 10:47 |
Company Presentation
MIDCAP Road Show - Paris
|
English | 3.4 MB | |
2025-05-15 15:26 |
Corporate Governance Report
Statuto sociale aggiornato
|
Italian | 295.1 KB | |
2025-05-15 15:25 |
General Meeting Notice
Verbale Assemblea ordinaria e straordinaria degli Azionisti del 26 aprile 2025
|
Italian | 9.4 MB | |
2025-05-15 15:23 |
AGM Report
Pharmanutra: Avviso deposito verbale Assemblea e Statuto aggiornato_Filing of m…
|
Italian | 172.3 KB | |
2025-05-14 11:46 |
Interim Report
Interim Management report as at March 31st, 2025
|
English | 1.7 MB | |
2025-05-14 11:45 |
Quarterly Report
Resoconto Intermedio di gestione al 31 Marzo 2025
|
Italian | 1.4 MB | |
2025-05-14 11:44 |
Interim Report
Avviso deposito Rendiconto Intermedio di gestione al 31 marzo 2025 || Notice of…
|
Italian | 177.0 KB | |
2025-05-12 17:30 |
Interim Report
Pharmanutra: CdA approva il Resoconto intermedio di gestione al 31 marzo 2025
|
Italian | 282.7 KB | |
2025-05-12 17:30 |
Interim Report
Pharmanutra: BoD approves the Intermin management report as of March 31, 2025
|
English | 349.0 KB | |
2025-05-06 17:02 |
Regulatory News Service
Allegato 3F - Aprile 2025
|
Italian | 92.0 KB | |
2025-04-22 16:41 |
Declaration of Voting Results & Voting Rights Announcements
PHARMANUTRA: Voting Summary Report
|
English | 341.1 KB | |
2025-04-22 16:40 |
Declaration of Voting Results & Voting Rights Announcements
Pharmanutra: Rendiconto sintetico delle votazioni
|
Italian | 322.7 KB | |
2025-04-22 16:39 |
Declaration of Voting Results & Voting Rights Announcements
Pharmanutra S.p.A.: Rendiconto sintetico delle votazioni (ITA/ENG)
|
Italian | 173.9 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Antibiotice S.A. | Romania | ATB | |
![]() |
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
![]() |
Asarina Pharma AB | Sweden | ASAP |